Market Research Logo

Low dosage Hydrate Inhibitors Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028

Low dosage Hydrate Inhibitors Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028

Market Introduction

Hydrate inhibitors are used in order to prevent the formation of gas hydrates at lower temperature and high pressure conditions. There are two types of hydrate inhibitors – thermodynamic inhibitors and low dosage hydrate inhibitors. Low dosage hydrate inhibitors are chemicals that help manage flow without the huge volume of chemicals that are required for thermodynamic inhibition. These are cost-effective chemicals and easy to use.

The primary advantages of low dosage hydrate inhibitors are that they require lower transportation costs, lower storage costs, and less maintenance; are effective during extended shut-ins; etc. Low dosage hydrate inhibitors are of two types – anti-agglomerate (AA) inhibitors and kinetic hydrate inhibitors (KHIs). They are mainly utilized in onshore and offshore operations in the oil and gas industry.

The report on the global low dosage hydrate inhibitors market studied the market for the next ten years, i.e. 2018-2028. The report has market values in 000’ US$ and market volumes in tons, and we have considered 2017 as the base year for the low dosage hydrate inhibitors market.

The report on the global low dosage hydrate inhibitors market has numerous sections that describe the entire scope of study, segment-wise. Initially, in the first section of the report, we have provided the executive summary of the global low dosage hydrate inhibitors market. In that, we have offered the outlook of the global low dosage hydrate inhibitors market

In the second section of the global low dosage hydrate inhibitors market report, we offer the market overview, market definition, and market taxonomy. In the next section, the report has key trends and Porter’s analysis of the global low dosage hydrate inhibitors market.

Next section of the global low dosage hydrate inhibitors market report has the entire outlook of the market background. Under this, we have included GDP outlook by region, offshore rigs by region, oil and gas production outlook, natural gas demand, natural gas production outlook, global energy consumption overview, chemical industry outlook, and patent analysis of the low dosage hydrate inhibitors market.

In the next section of the global low dosage hydrate inhibitors market, value chain analysis has been included along with a list of the distributors and manufactures of low dosage hydrate inhibitors. The global low dosage hydrate inhibitors market report has forecast factors, drivers, restrains, trends, and opportunity analysis for low dosage hydrate inhibitor manufactures. The next section of the report includes the pricing analysis by region, global value (000’ US$) and global volume (tons) analysis for the historical as well as the forecasted years. In the following section of the report, the value and volume analysis by segment (by product type, by terrain type, and by country) has been described for all regions – North America, Latin America, Europe, South East, East Asia, Oceania, and the Middle East & Africa.

The next section of the report includes the emerging market analysis, and comparison analysis of emerging and global markets by value and volume. PEST analysis for emerging economies has been included under this section. In the final section of the global low dosage hydrate inhibitors market report, we have included the competition benchmark, market analysis by tier, market concentration, competition dashboard, and company profiles of low dosage hydrate inhibitors.

In the competition analysis section, the report highlights some of the top companies operating in the global low dosage hydrate inhibitors market, such as BASF SE, Schlumberger Limited, Arkema Group, Baker Hughes Incorporated (BGHE), Clariant AG, Ecolab Inc., Evonik Industries AG, Force Chem Technologies LLC, Halliburton Co., and Gas Hydrate LLC, among others.

Research Methodology

Market volume for low dosage hydrate inhibitors are inferred through in-depth secondary research and validated from primary resources or interviews We have collected the data from private as well as public sources, such as – annual reports, newsletter, magazines, research papers, Factiva, BVD (Bureau van Dijk), etc. The price for low dosage hydrate inhibitors is analyzed on the basis of product type – anti-agglomerate and kinetic hydrate inhibitors (KHI), which is inferred across the all seven regions. The global value of the low dosage hydrate inhibitors market is thus calculated from the data gathered from secondary as well as primary resources, utilizing average price and market volume

For the next 10 years forecast of the low dosage hydrate inhibitors market, various market viewpoints, macroeconomic factors, and challenging trends are observed. For forecasting the market, we have considered both, supply-side trends and demand-side trends, and other dynamics that have an impact on the low dosage hydrate inhibitors market.

Forecast has been conducted in term of CAGR, Y-O-Y growth, and absolute dollar opportunity, presenting the client with crystal clear insights and future opportunities as far as the low dosage hydrate inhibitors market is concerned.


1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Taxonomy
2.2. Market Definition
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Development Trends
3.3. Porter’s Analysis
4. Key Success Factors
4.1. Product Adoption Rate
4.2. Technology Adoption Rate
4.3. Strategic Promotional Strategies
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Offshore Rigs By Region
5.1.3. Global Oil & Gas Production Forecast Outlook
5.1.4. Natural Gas Demand Forecast
5.1.5. Natural Gas Production By Region
5.1.6. Global Energy Consumption
5.1.7. Shale Gas Resources By country
5.1.8. Global Chemical Sales
5.1.9. Parent Market Outlook
5.1.10. Patent Analysis
5.2. Value Chain Analysis
5.2.1. List of Distributors
5.3. Forecast Factors - Relevance & Impact
5.4. Market Dynamics
5.4.1. Drivers
5.4.2. Restraints
5.4.3. Opportunity Analysis
6. Global Low Dosage Hydrate Inhibitors Market Demand Analysis 2013-2017 and Forecast, 2018-2028
6.1. Historical Market Volume (Tons) Analysis, 2013-2017
6.2. Current and Future Market Volume (Tons) Projections, 2018-2028
6.3. Y-o-Y Growth Trend Analysis
6.4. Pricing Analysis
6.5. Global Low Dosage Hydrate Inhibitors Market Demand (000’US$ ) Analysis 2013-2017 and Forecast, 2018-2028
7. Global Low Dosage Hydrate Inhibitors Market Analysis 2013-2017 and Forecast 2018-2028, by Product Type
7.1. Introduction / Key Findings
7.2. Historical Market Size (000’US$ ) and Volume Analysis By Product Type, 2013 - 2017
7.3. Current and Future Market Size (000’US$ ) and Volume Analysis and Forecast By Product Type, 2018 - 2028
7.3.1. Anti-Agglomerate (AA) inhibitors
7.3.2. Kinetic Hydrate Inhibitors (KHI)
7.4. Market Attractiveness Analysis By Product Type
8. Global Low Dosage Hydrate Inhibitors Market Analysis 2013-2017 and Forecast 2018-2028, by Terrain Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (000’US$ ) and Volume Analysis By Terrain Type, 2013 - 2017
8.3. Current and Future Market Size (000’US$ ) and Volume Analysis and Forecast By Terrain Type, 2018 - 2028
8.3.1. Onshore
8.3.2. Offshore
8.4. Market Attractiveness Analysis By Terrain Type
9. Global Low Dosage Hydrate Inhibitors Market Analysis 2013-2017 and Forecast 2018-2028, by Region
9.1. Introduction
9.2. Historical Market Size (000’US$ ) and Volume Analysis By Region, 2013 - 2017
9.3. Current Market Size (000’US$ ) and Volume Analysis and Forecast By Region, 2018 - 2028
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. East Asia
9.3.5. South Asia
9.3.6. Oceania
9.3.7. Middle East and Africa (MEA)
9.4. Market Attractiveness Analysis By Region
10. North America Low Dosage Hydrate Inhibitors Market Analysis 2013-2017 and Forecast 2018-2028
10.1. Introduction
10.2. Pricing Analysis
10.3. Historical Market Size (000’US$ ) and Volume Trend Analysis By Market Taxonomy, 2013 - 2017
10.4. Market Size (000’US$ ) and Volume Forecast By Market Taxonomy, 2018 - 2028
10.4.1. By Country
10.4.1.1. U.S.
10.4.1.2. Canada
10.4.2. By Product Type
10.4.3. By Terrain Type
10.5. Market Attractiveness Analysis
10.5.1. By Country
10.5.2. By Product Type
10.5.3. By Terrain Type
10.6. Market Trends
10.7. Key Market Participants - Intensity Mapping
10.8. Drivers and Restraints - Impact Analysis
11. Latin America Low Dosage Hydrate Inhibitors Market Analysis 2013-2017 and Forecast 2018-2028
11.1. Introduction
11.2. Pricing Analysis
11.3. Historical Market Size (000’US$ ) and Volume Trend Analysis By Market Taxonomy, 2013 - 2017
11.4. Market Size (000’US$ ) and Volume Forecast By Market Taxonomy, 2018 - 2028
11.4.1. By Country
11.4.1.1. Brazil
11.4.1.2. Mexico
11.4.1.3. Rest of Latin America
11.4.2. By Product Type
11.4.3. By Terrain Type
11.5. Market Attractiveness Analysis
11.5.1. By Country
11.5.2. By Product Type
11.5.3. By Terrain Type
11.6. Market Trends
11.7. Key Market Participants - Intensity Mapping
11.8. Drivers and Restraints - Impact Analysis
12. Europe Low Dosage Hydrate Inhibitors Market Analysis 2013-2017 and Forecast 2018-2028
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Size (000’US$ ) and Volume Trend Analysis By Market Taxonomy, 2013 - 2017
12.4. Market Size (000’US$ ) and Volume Forecast By Market Taxonomy, 2018 - 2028
12.4.1. By Country
12.4.1.1. Germany
12.4.1.2. Italy
12.4.1.3. France
12.4.1.4. U.K.
12.4.1.5. Spain
12.4.1.6. BENELUX
12.4.1.7. Russia
12.4.1.8. Rest of Europe
12.4.2. By Product Type
12.4.3. By Terrain Type
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Product Type
12.5.3. By Terrain Type
12.6. Market Trends
12.7. Key Market Participants - Intensity Mapping
12.8. Drivers and Restraints - Impact Analysis
13. South Asia Low Dosage Hydrate Inhibitors Market Analysis 2013-2017 and Forecast 2018-2028
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (000’US$ ) and Volume Trend Analysis By Market Taxonomy, 2013 - 2017
13.4. Market Size (000’US$ ) and Volume Forecast By Market Taxonomy, 2018 - 2028
13.4.1. By Country
13.4.1.1. India
13.4.1.2. Thailand
13.4.1.3. Indonesia
13.4.1.4. Malaysia
13.4.1.5. Rest of South Asia
13.4.2. By Product Type
13.4.3. By Terrain Type
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Product Type
13.5.3. By Terrain Type
13.6. Market Trends
13.7. Key Market Participants - Intensity Mapping
13.8. Drivers and Restraints - Impact Analysis
14. East Asia Low Dosage Hydrate Inhibitors Market Analysis 2013-2017 and Forecast 2018-2028
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (000’US$ ) and Volume Trend Analysis By Market Taxonomy, 2013 - 2017
14.4. Market Size (000’US$ ) and Volume Forecast By Market Taxonomy, 2018 - 2028
14.4.1. By Country
14.4.1.1. China
14.4.1.2. Japan
14.4.1.3. South Korea
14.4.2. By Product Type
14.4.3. By Terrain Type
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product Type
14.5.3. By Terrain Type
14.6. Market Trends
14.7. Key Market Participants - Intensity Mapping
14.8. Drivers and Restraints - Impact Analysis
15. Oceania Low Dosage Hydrate Inhibitors Market Analysis 2013-2017 and Forecast 2018-2028
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (000’US$ ) and Volume Trend Analysis By Market Taxonomy, 2013 - 2017
15.4. Market Size (000’US$ ) and Volume Forecast By Market Taxonomy, 2018 - 2028
15.4.1. By Country
15.4.1.1. Australia
15.4.1.2. New Zealand
15.4.2. By Product Type
15.4.3. By Terrain Type
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Product Type
15.5.3. By Terrain Type
15.6. Market Trends
15.7. Key Market Participants - Intensity Mapping
15.8. Drivers and Restraints - Impact Analysis
16. Middle East and Africa Low Dosage Hydrate Inhibitors Market Analysis 2013-2017 and Forecast 2018-2028
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (000’US$ ) and Volume Trend Analysis By Market Taxonomy, 2013 - 2017
16.4. Market Size (000’US$ ) and Volume Forecast By Market Taxonomy, 2018 - 2028
16.4.1. By Country
16.4.1.1. GCC Countries
16.4.1.2. Turkey
16.4.1.3. Northern Africa
16.4.1.4. South Africa
16.4.1.5. Rest of Middle East and Africa
16.4.2. By Product Type
16.4.3. By Terrain Type
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Product Type
16.5.3. By Terrain Type
16.6. Market Trends
16.7. Key Market Participants - Intensity Mapping
16.8. Drivers and Restraints - Impact Analysis
17. Emerging Countries Low Dosage Hydrate Inhibitors Market Analysis 2013-2017 and Forecast 2018-2028
17.1. Introduction
17.1.1. Market Value Proportion Analysis, By Key Countries
17.1.2. Global Vs. Country Growth Comparison
17.2. Canada Low Dosage Hydrate Inhibitors Market Analysis
17.2.1. Introduction
17.2.2. Pricing Analysis
17.2.3. PEST Analysis
17.2.4. Market Value Proportion Analysis by Market Taxonomy
17.2.5. Market Volume (Tons) and Value (000’US$ ) Analysis and Forecast by Market Taxonomy
17.2.5.1. By Product Type
17.2.5.2. By Terrain Type
17.2.6. Canada Low Dosage Hydrate Inhibitors Market - Competition Landscape
17.2.7. Canada - Trade Analysis
17.3. The U.S. Low Dosage Hydrate Inhibitors Market Analysis
17.3.1. Introduction
17.3.2. Pricing Analysis
17.3.3. PEST Analysis
17.3.4. Market Value Proportion Analysis by Market Taxonomy
17.3.5. Market Volume (Tons) and Value (000’US$ ) Analysis and Forecast by Market Taxonomy
17.3.5.1. By Product Type
17.3.5.2. By Terrain Type
17.3.6. The U.S. Low Dosage Hydrate Inhibitors Market - Competition Landscap
17.4. Brazil Low Dosage Hydrate Inhibitors Market Analysis
17.4.1. Introduction
17.4.2. Pricing Analysis
17.4.3. PEST Analysis
17.4.4. Market Value Proportion Analysis by Market Taxonomy
17.4.5. Market Volume (Tons) and Value (000’US$ ) Analysis and Forecast by Market Taxonomy
17.4.5.1. By Product Type
17.4.5.2. By Terrain Type
17.4.6. Brazil Low Dosage Hydrate Inhibitors Market - Competition Landscape
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies (Low Dosage Hydrate Inhibitors)
18.2. Market Concentration
18.3. Market Share Analysis of Top Players
18.4. Market Presence Analysis
18.4.1. By Regional footprint of Players
18.4.2. Product foot print by Players
18.4.3. Channel Foot Print by Players
19. Competition Analysis
19.1. Competition Dashboard
19.2. Pricing Analysis by Competition
19.3. Competition Benchmarking
19.4. Competition Deep Dive
19.4.1. BASF SE
19.4.1.1. Overview
19.4.1.2. Product Portfolio
19.4.1.3. Profitability by Market Segments (Product/Channel/Region)
19.4.1.4. Sales Footprint
19.4.1.5. Strategy Overview
19.4.1.5.1. Marketing Strategy
19.4.1.5.2. Product Strategy
19.4.1.5.3. Channel Strategy
19.4.2. Schlumberger
19.4.3. Arkema Group
19.4.4. Ashland
19.4.5. ERO CHEM LLC
19.4.6. Halliburton
19.4.7. Baker Hughes Incorporated
19.4.8. Clariant Chemicals
19.4.9. Ecolab
19.4.10. GasHydrate LLC
20. Assumptions and Acronyms Used
21. Research Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report